Content area

Abstract

Rationale

Ursolic acid (UA) has exhibited anti-inflammatory and anti-oxidative drug effects.

Objectives

In the research, we assessed the effects of UA on Nthy-ori 3-1 cells stimulated by IL-1β and attempted to elucidate the mechanisms underlying the effects.

Methods

Autoimmune thyroiditis (AIT) was simulated using Nthy-ori 3-1 cells by IL-1β (10 μM) treatment. UA (20 μM) was applied to ameliorate the injury of Nthy-ori 3-1 cells. The target of UA was predicted by TCMSP, BATMAN, and GEO database. Targeted relationship between lncRNA MALAT1 and miR-206, as well as miR-206 and PTGS1, was predicted by bioinformatics software and identified by dual luciferase assays. Cytokines in the cell supernatant and the apoptosis of cells were detected by ELISAs and flow cytometry assays, respectively. Expression levels of NF-κB signaling pathway-related proteins were estimated by western blot.

Results

By enquiring TCMSP, BATMAN, and GEO database, PTGS1 was identified as a target of UA. Afterward, a ceRNA network among MALAT1, miR-206, and PTGS1 was constructed. The expression levels of MALAT1 and PTGS1 in AIT tissues were obviously enhanced. Moreover, the ceRNA network formed by MALAT1/miR-206/PTGS1 contributed to the damage of Nthy-ori 3-1 cells induced by IL-1β. However, UA ameliorated the Nthy-ori 3-1 cells injury induced by IL-1β through mediating the MALAT1/miR-206/PTGS1 ceRNA network and NF-κB signaling pathway.

Conclusions

UA treatment significantly relieved the injury of Nthy-ori 3-1 cells via inhibiting the ceRNA mechanism of MALAT1/miR-206/PTGS1 and inflammatory pathways, insinuating that UA may be helpful for the treatment of AIT.

Details

Title
Ursolic acid ameliorates Nthy-ori 3-1 cells injury induced by IL-1β through limiting MALAT1/miR-206/PTGS1 ceRNA network and NF-κB signaling pathway
Author
Mou Lunpan 1 ; Liao Liyan 2 ; Zhang, Yaping 1 ; Desong, Ming 3 ; Jiang Jianjia 1 

 Quanzhou First Hospital Affiliated to Fujian Medical University, Department of Endocrinology, Quanzhou, China (GRID:grid.412683.a) (ISNI:0000 0004 1758 0400) 
 Central South University, Department of Pathology, The Second Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
 Quanzhou First Hospital Affiliated to Fujian Medical University, Department of Clinical Laboratory, Quanzhou, China (GRID:grid.412683.a) (ISNI:0000 0004 1758 0400) 
Pages
1141-1156
Publication year
2021
Publication date
Apr 2021
Publisher
Springer Nature B.V.
ISSN
00333158
e-ISSN
14322072
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2502065731
Copyright
© The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021.